-
Prostate cancer
-
Hormone-responsive breast cancer in perimenopausal (around menopause) women
-
Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus)
-
Central precocious puberty (a child’s body begins to change into an adult too soon caused by a release of certain hormones).
Sale!
PROLEMAX 11.25MG
2-8* C
LEUPROLIDE ACETATE 11.25MG
| MRP | : |
|
| Price | : | ₹4,250.00 |
| You Save | : | ₹5,062.19 (54.36%) |
1 Vial(s)
Prepaid Only. Non-Returnable.
This medicine is prepaid only and cannot be returned once delivered.
Prolemax 11.25mg Injection contains Leuprolide acetate as its active ingredient. It is classified as a Gonadotropin-Releasing Hormone (GnRH) agonist. This injection is indicated for the treatment of prostate cancer in men, hormone-sensitive breast cancer, endometriosis (a condition where tissue that typically lines the uterus grows outside of it), and uterine fibroids (noncancerous growths in the uterus) in women. Additionally, it is utilized in the management of premature puberty (central precocious puberty), a condition characterized by the early onset of adult physical features in children due to abnormal hormone secretion.
You should not receive this injection if you have a known allergy to Leuprolide acetate or any related substances, including Goserelin and Triptorlin. Prior to administration, it is essential to inform your healthcare provider if you have liver or kidney issues, or if you are experiencing unexplained abnormal uterine bleeding. This medication is contraindicated in pregnant women or those planning to conceive. During treatment, you may notice a temporary exacerbation of existing symptoms due to elevated sex steroid levels in the body. Discuss any concerns with your physician and report immediately if your child is diagnosed with a progressive brain tumor.
Before initiating treatment, it is important to inform your doctor of any pre-existing medical conditions, such as diabetes, seizures, cardiovascular issues (including chest pain or irregular heartbeats), depression, or osteoporosis (which increases the risk of bone thinning). This medication is not advised for use in pregnant or breastfeeding women, nor in patients experiencing abnormal vaginal bleeding. Women of reproductive age should utilize non-hormonal contraceptive methods while undergoing treatment with Prolemax 11.25mg Injection. Male patients should notify their healthcare provider if they have urinary obstruction, have had testicle removal surgery, or are experiencing spinal cord pressure, urinary issues, or hematuria (blood in urine).
For those seeking information on treatment and pricing for similar hormone-related therapies, Aggramed injection, also known as inj Aggramed or Aggramed inj, may be of interest.
